Search Results - "Kachestvennai͡a︡ klinicheskai͡a︡ praktika"

Refine Results
  1. 1

    Monitoring and safety assessment of drug-drug interactions in elderly patients by Sharaeva, A. T., Zurdinova, A. A., Satybaldieva, A. T.

    “…Most elderly patients have polymorbidity, have more frequent illnesses, and greater medical care needs. Each of the existing diseases requires constant drug…”
    Get full text
    Journal Article
  2. 2

    Pharmacotherapy with alpha-1 adrenergic blockers and lipid spectrum correction in patients with urinary disorders by Danilov, V. V., Eliseeva, E. V., Danilov, V. V., Volnykh, I. Yu, Tyrtyshnikova, A. V., Piskun, M. M., Danilov, V. V.

    “…The study was based on treatment outcomes in a group of 130 patients aged 18–81 years. Subgroups were formed according to gender and age criteria, which…”
    Get full text
    Journal Article
  3. 3

    Ineffectiveness of carbapenems in real-world clinical practice according to therapeutic drug monitoring data and Roszdravnadzor AIS reports by Zhukova, O. V., Chesnokova, N. N., Vorobeva, O. A., Pogodin, I. E., Shirokova, I. Yu

    “…Relevance . The use of carbapenems is associated with significant variability in pharmacokinetics/pharmacodynamics (FC/PD) parameters, particularly in…”
    Get full text
    Journal Article
  4. 4

    Pharmaceutical care for patients with headaches: pharmacists' statements and pharmacy practice by Reshetko, O. V., Grishin, A. I.

    “…Relevance . According to the World Health Organization, headaches are one of the most common symptoms of nervous system diseases. Pharmacists play an important…”
    Get full text
    Journal Article
  5. 5

    Possibility analysis of antiepileptic drugs import substitution in the Russian Federation by Bochanova, E. N., Gusev, S. D., Zhuravlev, D. A., Ignatyuk, A. V., Luneva, L. A., Chavyr, V. S., Shnayder, N. A.

    “…Relevance . Epilepsy is a common chronic disease of the nervous system that can be treated rationally, ensuring the possibility of remission in most patients…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Medical and biological research data by Martsinkevich, A. F.

    “…This paper discusses the importance of properly organizing data for effective statistical analysis. The main problems that arise when recording research…”
    Get full text
    Journal Article
  8. 8

    Evaluation of the effectiveness of the Program for Providing Certain Categories of Citizens with Necessary Medicines based on a sociological survey of physicians’ opinions by Eliseeva, E. V., Maneeva, E. S., Perelomova, O. V., Tyrtyshnikova, A. V., Savitskaya, D. V.

    “…The opinions of physicians regarding the effectiveness of the Program for Providing Certain Categories of Citizens with Necessary Medicines (Program) are the…”
    Get full text
    Journal Article
  9. 9

    Focus on lomefloxacin: effectiveness and safety by Khokhlov, A. L., Rybachkova, Ju. V.

    “…The results of clinical studies on the use of lomefloxacin for various diseases are presented. The purpose of this study was to analyze the effectiveness and…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Trends in clinical pharmacology as represented by international and specialized journals by Kolbin, A. S., Radaeva, K. S., Motrinchuk, A. S., Svechkareva, I. R.

    “…Relevance . Clinical pharmacology is a rapidly evolving field of medicine. The advent of modern technologies has led. The continued evolution of clinical…”
    Get full text
    Journal Article
  12. 12

    Socio-economic burden of chronic graft-versus-host disease after allogenic bone marrow transplantation by Kolbin, A. S., Gomon, Yu. M., Proskurin, M. A., Balykina, Ju. E.

    “…Aim . Chronic graft-versus-host disease (crGVHD) socio-economic burden assessment in the Russian Federation. Materials and methods . The assessment was…”
    Get full text
    Journal Article
  13. 13

    A logistic regression-based model to predict ICU mortality: problems and solutions by Luchinin, A. S., Lyanguzov, A. V.

    “…The ICU department’s mortality rate is one of the most important indicators of quality of care. Based on real clinical data, we attempted to build a prognostic…”
    Get full text
    Journal Article
  14. 14

    Socioeconomic and global burden of COVID-19 by Kolbin, A. S., Gomon, Yu. M., Balykina, Yu. E., Belousov, D. Yu, Strizheletskiy, V. V., Ivanov, I. G.

    “…Relevance . Assessment of the burden of disease provides information on the economic consequences of the disease, allows you to assess the social significance,…”
    Get full text
    Journal Article
  15. 15

    Rationality of routine clinical use of olokizumab in COVID-19 by Tsvetov, V. M., Matveev, A. V., Sychev, D. A.

    “…Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials…”
    Get full text
    Journal Article
  16. 16

    Possibilities for the use of anakinra in COVID-19 by Otdelenov, V. A., Matveev, A. V., Sychev, D. A.

    “…The use of anakinra cannot be currently recommended outside of clinical trials as pathogenetic treatment of “cytokine storm” in severe COVID-19…”
    Get full text
    Journal Article
  17. 17

    Possibilities for the use of tofacitinib in patients with COVID-19 by Matveev, A. V., Kiselev, Yu. Yu, Sychev, D. A.

    “…No published trials measuring effectiveness of tofacitinib in COVID-19 have been identified. Some professional associations recommend discontinuing tofacitinib…”
    Get full text
    Journal Article
  18. 18

    Current and future use of vitamin D3 in patients with COVID-19 by Sychev, I. N., Matveev, A. V., Sychev, D. A.

    “…There is currently no evidence for vitamin D3 effectiveness for COVID-19 treatment and prevention…”
    Get full text
    Journal Article
  19. 19

    Pragmatic clinical trials by Shevchenko, O. R., Kolbin, A. S.

    “…Pragmatic clinical trials (PCTs) allow combining the advantages of observational trials in real-world evidence with the scientific rigor of randomized clinical…”
    Get full text
    Journal Article
  20. 20